Jump to a section
Choose your BPC-157 product
Online ordering is not available yet.
BPC-157 10 mg vial
Freeze-dried BPC-157 powder.
- Preparation
- Reconstitution
- Storage, sealed
- −20°C
- Documented lot
- PL-2609-010
- HPLC purity
- 99.74%
BPC-157 15 mg pen
Prefilled liquid. No powder mixing.
- Liquid volume
- 3 mL
- Concentration
- 5 mg/mL
- Preparation
- Already dissolved
- Storage
- 2–8°C · do not freeze
BPC-157 capsules
60 capsules. 30 mg total per bottle.
- Bottle size
- 60 capsules
- Total BPC-157
- 30 mg
- Documented lot
- PL-2609-012
- HPLC purity
- 99.62%
BPC-157 nasal spray
30 mg in a premixed spray bottle.
- Total BPC-157
- 30 mg
- Format
- Metered pump
- Preparation
- Premixed liquid
- Storage
- 2–8°C · do not freeze
For laboratory research use only. Vial and capsule COAs are in-house reports for the named lots. Spray strength follows the reference product label.
BPC-157 10 mg vial
10 mg of freeze-dried BPC-157 in one vial. The powder requires reconstitution; the final liquid volume sets its concentration. [1]
- Contents
- 10 mg BPC-157
- Format
- Freeze-dried powder
- Preparation
- Reconstitution required
Storage: keep the sealed dry vial at −20°C, dry and protected from light. After preparation, follow the solution’s separate storage and use limit.
Batch documentation: lot PL-2609-010; 99.74% HPLC area purity. View the redacted vial COA → [2]
BPC-157 prefilled pen — 15 mg
15 mg of BPC-157, already dissolved in a 3 mL pen at 5 mg/mL. No powder mixing or added water. The formulation contains bacteriostatic water with 0.9% benzyl alcohol. [1]
Liquid in the pen
Concentration
Total BPC-157
Storage: refrigerate at 2–8°C in the original carton, protected from light. Do not freeze.
Dial settings: use the instructions for this exact device. The product record does not specify the volume or BPC-157 amount delivered per click.
Documentation: quantity and formulation specifications are available. A finished-pen COA has not been supplied.
BPC-157 capsules — 500 mcg × 60
500 mcg per capsule, 60 capsules per bottle, 30 mg total. A counted capsule format with no reconstitution or liquid measurement. [1]
- Each capsule
- 500 mcg BPC-157
- Bottle size
- 60 capsules
- Total content
- 30 mg BPC-157
Ingredients: BPC-157, microcrystalline cellulose and a hard gelatin shell.
Storage: 20–25°C, dry and protected from light. Keep the original bottle tightly closed.
Batch documentation: lot PL-2609-012; 99.62% HPLC area purity and a separate content assay averaging 494.7 mcg per capsule across six capsules. View the redacted capsule COA → [3]
BPC-157 nasal spray — 30 mg
150 mcg per spray, 30 mg per bottle. Premixed liquid in a metered pump; no powder reconstitution. [1]
- Each spray
- 150 mcg BPC-157
- Bottle content
- 30 mg BPC-157
- Format
- Premixed metered pump
Formulation: BPC-157 in bacteriostatic water with 0.9% benzyl alcohol.
Storage: refrigerate at 2–8°C, upright with the cap on and protected from light. Do not freeze.
150 mcg and 30 mg are the reference-label specifications; confirm the current bottle label. A finished-spray COA and usable spray count have not been supplied.
Compare formats at a glance
| Product | Contents | Preparation | Storage |
|---|---|---|---|
| 10 mg vial | 10 mg per vial | Reconstitution required | Sealed powder: −20°C, dry and dark |
| 15 mg pen | 3 mL at 5 mg/mL | Prefilled liquid | 2–8°C; do not freeze |
| 500 mcg capsules | 60 capsules; 30 mg total | No mixing | 20–25°C, closed and dry |
| 30 mg nasal spray | 150 mcg per spray | Premixed pump | 2–8°C; do not freeze |
Product storage specifications. Prepared-vial storage differs from sealed-powder storage. [1]
Comparing BPC-157 capsules and arginate
Compare the amount per capsule, not only the number on the front of the bottle. A serving can contain more than one capsule. These products contain 500 mcg in each capsule, so 60 capsules provide 30 mg. [1]
| Label wording | BPC-157 per capsule | Total in 60 capsules |
|---|---|---|
| 500 mcg per capsule — supplied product | 500 mcg | 30 mg |
| 500 mcg per two-capsule serving — comparison example | 250 mcg | 15 mg |
The same “500 mcg” headline can therefore describe bottles with different total contents. The serving-size example is label arithmetic, not a second product offered here.
Arginate versus acetate
Arginate refers to an arginine salt of BPC-157; acetate is another chemical form. The arginate patent describes improved stability in laboratory tests, including simulated gastric fluid. It does not establish better injury recovery or a particular percentage absorbed in humans. [4]
Salt identity and capsule design are separate details. “Arginate” does not automatically mean delayed release, and the word “capsule” does not identify a salt. The supplied capsule specifications do not name an arginate form or a delayed-release coating. They list BPC-157, microcrystalline cellulose and a hard gelatin shell. [1] [5]
BPC-157 cost per mg and per capsule
Divide the product price by its total labelled BPC-157 to compare cost per mg. A larger bottle can cost more upfront while costing less per mg. Use the same format for a meaningful price comparison; 30 mg swallowed is not an established substitute for 30 mg injected.
| Product | Cost per labelled mg | Useful unit comparison |
|---|---|---|
| 10 mg vial | Vial price ÷ 10 | Include any separately supplied preparation materials |
| 15 mg pen | Pen price ÷ 15 | Prefilled device; no separate powder mixing |
| 60 × 500 mcg capsules | Bottle price ÷ 30 | Bottle price ÷ 60 = cost per capsule |
| 30 mg nasal spray | Bottle price ÷ 30 | 200 nominal 150 mcg amounts before priming and residual liquid |
Calculations use the listed contents. Retail prices are not listed, so a dollar comparison is not available. Shipping, accessories and product losses can change the final cost.
Redacted BPC-157 COAs
Redacted certificates for vial lot PL-2609-010 and capsule lot PL-2609-012. Both are in-house reports, analysed on 19 September 2026 and issued on 3 October 2026. [2] [3]
BPC-157 10 mg vial — lot PL-2609-010
BPC-157 capsules — lot PL-2609-012
These reports cover the named vial and capsule lots. They do not test the finished pen or spray. The vial’s 10 mg is its label amount; a separate fill-content assay is not listed.
Lab results: purity, identity and content
Purity, identity and quantity are different tests. A high purity percentage does not, by itself, confirm how many milligrams are in the vial.
| Test | Measurement | Result in the supplied reports |
|---|---|---|
| LC-MS identity | Molecular mass matched against the peptide identity | 1419.8 Da in both reports |
| HPLC area purity | BPC-157’s share of the measured chromatographic signal | 99.74% vial · 99.62% capsules |
| Content assay | Amount of BPC-157 in the sampled unit | 494.7 mcg per capsule from a six-capsule composite; no separate vial fill-content assay |
| Sterility and endotoxin | Results of the stated contamination tests on the sample | No growth after 14 days; 0.05 EU/mg endotoxin |
Redacted in-house reports for the named lots. A six-capsule composite does not give each capsule’s individual content, and a powder-lot test does not establish the condition of a separately filled pen or spray. [2] [3]
BPC-157 alone or the Wolverine blend
All four products contain BPC-157 without TB-500. Wolverine combines both peptides. See the BPC-157 + TB-500 blend →
Questions & answers.
Does the prefilled pen need mixing?
No. It contains 15 mg of BPC-157 already dissolved in 3 mL, at 5 mg/mL. Do not add water to the pen.
How many capsules are in the bottle?
60 capsules, each labelled 500 mcg, for 30 mg of BPC-157 per bottle.
Are the capsules gelatin-free?
No. They use a hard gelatin shell and microcrystalline cellulose filler.
Which products have redacted COAs?
The 10 mg vial and 500 mcg capsules have redacted in-house batch reports. Open the PDFs in the COA section. Finished-pen and finished-spray reports have not been supplied.
Does the spray need refrigeration?
Yes. Keep it at 2–8°C, upright with the cap on and protected from light. Do not freeze it.
Are diluent, needles or other accessories included?
Additional diluent, needles and spare accessories are not confirmed in the product records. They are not listed as included items.
How much BPC-157 does one pen click deliver?
The concentration is 5 mg/mL. The amount per click depends on the exact device, and its click-to-volume calibration is not specified in the available product record.
Does “500 mcg” mean per capsule or per serving?
For the supplied bottle it means 500 mcg in each capsule. Other labels can state an amount per serving, and a serving can contain two or more capsules. Check both lines before comparing total contents.
Are these BPC-157 arginate capsules?
An arginate form is not specified in the supplied product record. The listed ingredients are BPC-157, microcrystalline cellulose and a hard gelatin shell.
Sources & batch documents5 references · expand to read
- Product specifications and handling information for the four BPC-157 formats, checked 5 November 2026 ↗
- Redacted supplied COA: BPC-157 10 mg, lot PL-2609-010, certificate PL-26-00010 ↗
- Redacted supplied COA: BPC-157 capsules, lot PL-2609-012, certificate PL-26-00012 ↗
- US9850282B2: BPC-157 salts and laboratory stability experiments; not a human efficacy trial ↗
- FDA 2026 review: BPC-157 chemical forms and product-characterisation requirements ↗